Details for New Drug Application (NDA): 011777
✉ Email this page to a colleague
NDA 011777 describes SODIUM PHOSPHATE P 32, which is a drug marketed by Mallinckrodt and is included in one NDA. Additional details are available on the SODIUM PHOSPHATE P 32 profile page.
The generic ingredient in SODIUM PHOSPHATE P 32 is sodium phosphate p-32. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium phosphate p-32 profile page.
The generic ingredient in SODIUM PHOSPHATE P 32 is sodium phosphate p-32. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium phosphate p-32 profile page.
Summary for 011777
| Tradename: | SODIUM PHOSPHATE P 32 |
| Applicant: | Mallinckrodt |
| Ingredient: | sodium phosphate p-32 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INJECTION, ORAL | Strength | 0.67mCi/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INJECTION, ORAL | Strength | 1.5mCi/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
